MPO and Abnormal intestine morphology: In rats with indomethacin-induced enteropathy, administration of Lubiprostone (0.1 mg/kg) suppressed myeloperoxidase (MPO) activity, reduced TNF-α expression, and prevented bacterial invasion in small intestines [151].